ARTICLE | Clinical News
Theliatinib: Phase I started
November 12, 2012 8:00 AM UTC
Hutchison's Hutchison MediPharma Ltd. majority-owned subsidiary began a Chinese Phase I trial to evaluate single and repeat doses of oral theliatinib in patients with advanced solid tumors. ...